The American Geriatrics Society (AGS) Beers Criteria® for Potentially Inappropriate Medication (PIM) Use in Older Adults is a widely recognized and utilized tool in the healthcare community. The AGS Beers Criteria is regularly updated every 3-4 years to ensure its relevance and accuracy in guiding healthcare professionals in prescribing medications for individuals aged 65 and […]
A list of all the FDA approved medications in July 2024.
A list of clinical practice guidelines and guideline summaries that were updated or published in July 2024.
In the latest installment of our Guidelines International Series, we will be delving into the latest guidelines from the World Health Organization (WHO). Established in 1948, WHO is a specialized agency of the United Nations (UN) that facilitates collaboration between nations, partners, and individuals to advance global health, ensure global security, and support marginalized populations. […]
Today we’re going to look at the ongoing studies and clinical trials specific to soft tissue sarcomas in adults. The below list was curated by assessing the ongoing Phase 3 trials for soft tissue sarcomas, specific to adults, and based in the United States. The dates provided are estimates, and subject to change. The list […]
We understand the critical role you play in supporting patients and communities impacted by substance use and mental health disorders. To aid your efforts, we’ve compiled a comprehensive list of essential guidelines from leading medical societies published in recent years. These guidelines are designed to enhance your practice and improve patient outcomes. Your dedication to […]
Today, we will explore the latest research and clinical trials focused on the management of hemochromatosis. The following list has been carefully curated by evaluating ongoing trials related to hemochromatosis in the United States. Please note that the dates provided are approximate and may be subject to change. The list primarily includes studies with results […]
A list of all the FDA approved medications in June 2024.
A list of clinical practice guidelines and guideline summaries that were updated or published in June 2024.
We’re going to take a look at the ongoing studies and clinical trials specific to juvenile arthritis. The below list was curated by assessing the ongoing Phase 3 trials for juvenile arthritis that are based in the United States. The dates provided are estimates, and subject to change. The list is primarily studies that have […]
Today we’re going to look at the ongoing studies and clinical trials specific to gout in adults. The below list was curated by assessing the ongoing Phase 3 trials for gout, specific for adults, and based in the United States. The dates provided are estimates, and subject to change. The list is primarily studies that […]
Today we’re going to look at the ongoing studies and clinical trials specific to celiac disease in adults. The following list has been curated by evaluating the current Phase 2 and 3 clinical trials for celiac disease in adults conducted in the United States. Please note that the dates provided are approximate and may be […]
Today we’re going to cover the second article in a two part series that takes a look at the ongoing studies and clinical trials specific to management of migraine in adults, including acute migraine treatment and migraine prevention (both chronic migraine prevention and episodic migraine prevention). The focus of Part 1 was Acute Migraine Treatment […]
Breyanzi (Bristol Myers Squibb)Expanded Indication Retevmo (Eli Lilly) Expanded Indication Onyda XR (Tris Pharma) Bkemv (Amgen)Biosimilar to Soliris Opuviz (Biogen) Biosimilar to Eylea Yesafili (Biocon Biologics) Biosimilar to Eylea Imdelltra (Amgen) Clinolipid (Baxter) Expanded Indication ColoSense (Geneoscopy) New Formulation Myhibbin (Azurity Pharmaceuticals) New Formulation Cyltezo (Boehringer Ingelheim) New Formulation Sign up for alerts and stay informed on […]
Sign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2024 Guideline Central, All rights reserved.
For this installment of our Guidelines Side-By-Side Series, we’re going to take a look at the current guidelines for atopic dermatitis (AD), commonly referred to as eczema. It is a chronic inflammatory skin condition, identified by dry, itchy skin that may release clear fluid when scratched. The National Institutes of Health (NIH) estimates that this […]
Today we’re going to look at the ongoing studies and clinical trials specific to management of schizophrenia in adults, including in acutely psychotic people with schizophrenia and relapse prevention. The below list was curated by assessing the ongoing Phase 3 trials for migraine treatments, specific for adults, and based in the United States. The dates […]
For the next installment of our Guidelines Side-By-Side series, we’re going to take a look at the current guidelines for liver cancer. This article will examine how the recommendations in each guideline agree, contradict, or otherwise differ. Our topic for today will be systemic treatment for metastatic hepatocellular carcinoma. The focus will be limited to […]
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.